Published in
American Association for the Advancement of Science, Science Translational Medicine, 487(11), 2019
DOI: 10.1126/scitranslmed.aau3259
Links
Tools
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Journal article published in 2019 by
Jun Ishihara 
,
Ako Ishihara ,
Koichi Sasaki ,
Steve Seung-Young Lee ,
John-Michael Williford ,
Mariko Yasui,
Lambert Potin ,
Michal M. Raczy ,
Hiroyuki Abe,
Aslan Mansurov ,
Kiyomitsu Katsumata ,
Kazuto Fukunaga ,
Peyman Hosseinchi ,
Stephen J. Kron ,
Laura T. Gray
and other authors.
,
Ako Ishihara ,
Koichi Sasaki ,
Steve Seung-Young Lee ,
John-Michael Williford ,
Mariko Yasui,
Lambert Potin ,
Michal M. Raczy ,
Hiroyuki Abe,
Aslan Mansurov ,
Kiyomitsu Katsumata ,
Kazuto Fukunaga ,
Peyman Hosseinchi ,
Stephen J. Kron ,
Laura T. Gray
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
An engineered cancer immunotherapy using a collagen-binding domain enhances efficacy and reduces adverse events.